| Literature DB >> 36011087 |
Inmaculada Aguiar-Díaz1, María Victoria Ruiz-Mallorquí1, Beatriz González-López Valcarcel2.
Abstract
The objective of this paper was to estimate the influence of being affiliated with an NH chain on perceived consumer quality, and whether this relationship is affected by maintaining a collaboration agreement with public administrations. We used a combination of theoretical foundations: (1) From the consumer perspective, we focussed on online reviews of the quality of nursing homes (NHs); (2) from the industrial organisation literature, we proposed arguments regarding the advantages and disadvantages of belonging to a chain; (3) the theory of transaction costs was used to explain public-private collaboration. The study was carried out on a sample of 642 chain-affiliated Spanish NHs, with data from quality scores downloaded from the website topMayores.es. We distinguished between the six largest chains and the rest. We applied linear regression models. The results show that NHs affiliated with one of the largest NH chains obtained worse quality scores in the assessment made by users, although quality scores improved for the largest chains of NHs involved in an agreement with the public administration.Entities:
Keywords: commissioning; largest chains; nursing homes; quality
Year: 2022 PMID: 36011087 PMCID: PMC9408552 DOI: 10.3390/healthcare10081431
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Distribution of the sample of private NHs affiliated to a chain.
| Initial Sample | Final Sample | NHs with Agreement (%) | Number of Provinces | Provincial Concentration (% of Top 3 NHs) | |
|---|---|---|---|---|---|
| Total | 921 | 642 | 63.86 | 49 | 45.02 |
| No Big6 | 423 | 260 | 47.31 | 39 | 50.77 |
| Big6 | 498 | 382 | 75.13 | 46 | 42.15 |
| DomusVi | 273 | 173 | 17.34 | 32 | 31.79 |
| Ballesol | 41 | 39 | 65.62 | 16 | 48.72 |
| Amavir | 35 | 34 | 100.00 | 8 | 82.35 |
| Orpea | 63 | 60 | 28.33 | 17 | 65.00 |
| Vitalia | 40 | 36 | 11.11 | 14 | 47.22 |
| Sanitas | 46 | 40 | 57.50 | 14 | 70.00 |
Descriptives.
| All | With Commissioning (COM) | No Commissioning (NoCOM) | |||||
|---|---|---|---|---|---|---|---|
| Average | SD | Average | SD | Average | SD | COM_NoCOM | |
| Total | 3.26 | 1.14 | 3.29 | 1.13 | 3.19 | 1.17 | −1.16 |
| No Big6 | 3.39 | 1.21 | 3.35 | 1.21 | 3.43 | 1.20 | 0.54 |
| Big6 | 3.16 | 1.09 | 3.27 | 1.09 | 2.83 | 1.03 | −3.44 *** |
| 2.49 ** | 0.63 | 3.93 *** | |||||
| DomusVi | 3.33 | 1.12 | 3.47 | 1.04 | 2.64 | 1.20 | −3.87 *** |
| Ballesol | 3.15 | 0.86 | 3.12 | 1.10 | 3.17 | 0.60 | 0.15 |
| Amavir | 3.92 | 0.81 | 3.92 | 0.81 | - | - | - |
| Orpea | 2.50 | 0.92 | 2.37 | 0.84 | 2.83 | 1.07 | 1.75 * |
| Vitalia | 2.85 | 1.05 | 2.97 | 1.03 | 1.87 | 0.63 | −2.06 ** |
| Sanitas | 3.09 | 0.17 | 3.28 | 1.18 | 2.95 | 1.04 | −0.95 |
| K-Wallis | 47.24 *** | 49.12 *** | 9.19 * | 11.52 *** | |||
K-Wallis test of equality of the six Big chains. *, ** and ***: significant at 10%, 5% and 1%, respectively.
Correlations and Variance Inflation Factor (VIF).
| Score | Big6 | Commis. | Size | GDP p.c. | HHI | |
|---|---|---|---|---|---|---|
| Average | 3.2578 | 0.5950 | 0.6386 | 4.7828 | 10.2225 | 118.7048 |
| SD | 1.1457 | 0.4912 | 0.4807 | 0.5587 | 0.2304 | 100.7908 |
| VIF | 1.24 | 1.10 | 1.14 | 1.42 | 1.44 | |
| Score | 1.0000 | |||||
| Big6 | −0.0983 * | 1.0000 | ||||
| Commissioning | 0.0458 | 0.2843 *** | 1.0000 | |||
| Size (log) | −0.1868 *** | 0.3453 | 0.1563 *** | 1.0000 | ||
| GDPper capita (log) | −0.0180 | −0.0753 * | 0.0256 | 0.0221 | 1.0000 | |
| HHI (log) | −0.0610 | 0.1444 *** | 0.0657 * | −0.0012 | −0.5394 *** | 1.0000 |
K-Wallis test of equality of the six Big chains. *, *** significant at 10% and 1%, respectively.
Econometric results.
| Model 1 | Model 2 | Model 3 | ||||
|---|---|---|---|---|---|---|
| β | S.E. | β | S.E. | β | S.E. | |
| Big6 |
| −0.1555 | - | - | - | - |
| Commissioning | −0.0099 | 0.1395 |
| 0.0979 | −0.0136 | 0.1348 |
| Big6xCOM |
| 0.1922 | - | - | - | - |
| DomusVi | - | - | 0.0154 | 0.1184 |
| 0.2254 |
| Ballesol | - | - | −0.0833 | 0.1975 | −0.0932 | 0.2585 |
| Amavir | - | - |
| 0.2102 |
| 0.2138 |
| Orpea | - | - |
| 0.1623 |
| 0.2814 |
| Vitalia | - | - |
| 0.2032 |
| 0.5497 |
| Sanitas | - | - | −0.1642 | 0.1876 | −0.3621 | 0.2449 |
| DomusVixCOM | - | - | - | - |
| 0.2568 |
| BallesolxCOM | - | - | - | - | −0.0099 | 0.3723 |
| OrpeaxCOM | - | - | - | - | −0.3532 | 0.3399 |
| VitaliaxCOM | - | - | - | - |
| 0.5880 |
| SanitasxCOM | - | - | - | - | 0.4148 | 0.3704 |
| Size | −0.3564 *** | 0.0846 | −0.3468 *** | 0.0829 | −0.3184 *** | 0.0827 |
| HHI | −0.0011 ** | 0.0005 | −0.0014 *** | 0.0005 | −0.0014 *** | 0.0005 |
| GDP per capita | −0.3892 * | 0.2280 | −0.4991 ** | 0.2299 | −0.4446 * | 0.2296 |
| Constant | 9.1222 *** | 2.3864 | 10.1506 *** | 2.4010 | 9.5435 *** | 2.4012 |
| N. Obs | 642 | 642 | 642 | |||
| R-squared | 0.0599 | 0.1128 | 0.1347 | |||
Dependent variable: quality score. Estimation method: OLS linear regression. *, ** and ***: significant at 10%, 5% and 1%, respectively.
Econometric results. Robustness.
| Model 4 | Model 5 | Model 6 | Model 7 | |||||
|---|---|---|---|---|---|---|---|---|
| Subsample | Big6 | No Big6 | With Commissioning | No Commissioning | ||||
| β | S.E. | β | S.E. | β | S.E. | β | S.E. | |
| Big6 | - | - | - | - | 0.1009 | 0.1252 |
| 0.1648 |
| Commissioning |
| 0.1259 | −0.0254 | 0.1506 | - | - | - | - |
| Size | −0.4424 *** | 0.1242 | −0.3066 ** | 0.1202 | −0.5111 *** | 0.1146 | −0.1802 | 0.1296 |
| HHI | −0.0015 ** | 0.0006 | −0.0004 | 0.0010 | −0.0012 ** | 0.0006 | −0.0013 | 0.0009 |
| GDP per capita | −0.4336 | 0.2773 | −0.3009 | 0.3918 | −0.2952 | 0.2732 | −0.5231 | 0.4142 |
| Constant | 9.6306 *** | 2.9136 | 7.9276 * | 4.0906 | 8.8779 *** | 2.8536 | 9.7227 ** | 4.3458 |
| N. Obs | 382 | 260 | 410 | 232 | ||||
| R-squared | 0.0732 | 0.0286 | 0.0535 | 0.0805 | ||||
Dependent variable: quality score. Estimation method: OLS linear regression. *, ** and *** significant at 10%, 5% and 1%, respectively.